Biotech Pharmaceuticals News

(AFX UK Focus) 2010-03-23 08:50 Merck KGaA to issue bonds regularly -CFO in paper

March 30, 2010 By biotech-source.com Leave a Comment

(AFX UK Focus) 2010-03-23 08:50 Merck KGaA to issue bonds regularly -CFO in paper
FRANKFURT, March 23 (Reuters) – German pharmaceutical company Merck KGaA expects to raise funds on the bond market on a regular basis, its chief financial officer said in a newspaper interview. “Under our (bond) programme we will regularly act as an issuer on the bond market,” Michael Becker told Boersen-Zeitung in an interview published on Tuesday. Last week, Merck issued a 3.2 billion euro ($4 …

Ageing: Much ado about ageing

March 30, 2010 By biotech-source.com Leave a Comment

Ageing: Much ado about ageing
Questions about a laboratory assay are making Sirtris, a high-profile biotechnology company, the talking point of the ageing field. Heidi Ledford investigates.

Big Pharma Wins Big in Health Care Reform

March 30, 2010 By biotech-source.com Leave a Comment

Big Pharma Wins Big in Health Care Reform
The Republicans look a sour lot this morning, but the pharmaceutical industry, which helps foot the campaign bills of a sizeable chunk of members of both parties, is delighted with the legislation, and with its Democratic friends in the White House and on the Hill.

Read more on Baltimore Chronicle & Sentinel

Filed Under: Biotech Pharmaceuticals News Tagged With: Baltimore Chronicle, Care, Democratic Friends, Health, Health Care Reform, Legislation, Pharma, Pharmaceutical Industry, reform, Republicans, Sentinel, Sizeable Chunk, White House, Wins

State Tax Credit Bill Sets Off Confusion

March 30, 2010 By biotech-source.com Leave a Comment

State Tax Credit Bill Sets Off Confusion
Fred V. Carstensen didn’t hold back when he implored lawmakers to move ahead with a jobs plan that he said would speed the state’s economic recovery dramatically.

Solazyme, Inc. – Pharmaceuticals & Healthcare – Deals And Alliances Profile – New Report Published

March 29, 2010 By biotech-source.com Leave a Comment

Solazyme, Inc. – Pharmaceuticals & Healthcare – Deals And Alliances Profile – New Report Published
Solazyme, Inc. is a biotech company. The company is engaged in the development of wide range solutions for the renewable energy, industrial chemical and cosmetic, nutritional and pharmaceutical markets.

(AFX UK Focus) 2010-03-23 08:50 Merck KGaA to issue bonds regularly -CFO in paper

Ageing: Much ado about ageing

Big Pharma Wins Big in Health Care Reform

State Tax Credit Bill Sets Off Confusion

Solazyme, Inc. – Pharmaceuticals & Healthcare – Deals And Alliances Profile – New Report Published

Rapid Review Biochemistry: With STUDENT CONSULT Online Access

Lehninger Principles of Biochemistry & eBook

Lippincott’s Illustrated Reviews: Biochemistry, North American Edition

Biochemistry For Dummies